Lutein/zeaxanthin benefits for people with low dietary intakes is an ‘important message’ for the general population: OmniActive COO
08-May-2013 - The significant benefits of adding lutein and zeaxanthin to the AREDS formula for people with low dietary intakes of the carotenoids is an ‘important message’, especially since a large portion of the population has low levels, says the COO of OmniActive.
Lutein + zeaxanthin may reduce risk of progression to advanced AMD, compared to original AREDS formula
06-May-2013 - Adding lutein, zeaxanthin and/or omega-3 fatty acids to the AREDS eye health formula may not offer any additional benefits regarding age-related macular degeneration (AMD) risk, says the much anticipated AREDS2 data.
Warning letters show companies still vague on nature of website language
01-May-2013 - Now, almost 20 years after DSHEA became law, some companies seem to be just starting to get the message that the regulations governing health claims language don’t apply just to product labels. Websites are fair game, too, and can form easy pickings for regulators.
Lutein, zeaxanthin plus omega-3 shows benefits for AMD sufferers
27-Mar-2013 - A combination of lutein, zeaxanthin and omega-3 long-chain polyunsaturated fatty acids may boost the pigment in the retina and help people with age-related macular degeneration (AMD), says new data from Germany.
LycoRed's new carotenoid beadlet system enhances stability, flexibility
22-Mar-2013 - LycoRed has extended its line of carotenoid coatings with a new beadlet system that will function both for tablets and beverages.
Astaxanthin: Still red hot or cooling off? The Dr Oz effect… two years on
15-Mar-2013 - Rewind two years, and astaxanthin was the hottest nutraceutical in town, with sales “skyrocketing” following a slot on Dr Oz in which Dr Joseph Mercola described the potent red antioxidant as the “number one supplement you’ve never heard of that you should be taking”.
Prof Blumberg: We need reference intakes for phytochemicals (and we’re not calling them antioxidants)
15-Mar-2013 - Establishing some kind of intake recommendations for polyphenols and carotenoids will spur innovation and allow for rational synergies of phytochemicals with specific health outcomes, says Prof Jeffrey Blumberg from Tufts University.
Finding the sweet spot in the algal omega-3 market
21-Feb-2013 - Most experts say we have barely scratched the surface when it comes to exploring the commercial potential of microalgae. But who is best-placed to translate this promise into hard cash in the food and dietary supplement market?
UK venture capitalists eye expansion at Israeli antioxidant specialists
18-Feb-2013 - Southern Israel-based algae-sourced astanxanthin specialists Algatechnologies has won investment from a UK venture capitalist in a move that will broaden its capacity, R&D and distribution scope for the eye and skin health carotenoid.
Cyanotech posts record sales, marred only by production issues, legal fees
13-Feb-2013 - Microalgae producer Cyanotech recorded a record $7.2 million in sales in the third quarter, an 8% rise year-over-year. Net income declined, however, coming at at $607,000 compared to $1.1 million a year earlier.
Lutein pills may boost night vision: RCT
29-Jan-2013 - Daily supplements of lutein may improve vision and help with tasks such as driving at night, say data from a randomized, double-blind, placebo-controlled trial.
Zinc benefitting from EU health claims game
24-Jan-2013 - Used in cigarette filters, as a corrosive, pigment and in the manufacture of rubber and concrete, zinc forms like zinc oxide and zinc suphate are also important nutrients for physiological wellbeing. And 18 new European Union health claims – the most of any mineral – may open new avenues.
Kemin: 'Statement that all three carotenoids found in the macula may be needed in a formulation is premature'
23-Jan-2013 - The statement by eye health researchers that all three carotenoids found in the macula may be needed in a formulation to boost levels of these carotenoids in the macula is 'premature', say leading scientists from Kemin.
Comment is free, but fact is sacred: The 3 macular carotenoids are required to enrich macular pigment and optimise vision
22-Jan-2013 - Claims that meso-zeaxanthin is not required for eye health formulations in addition to the established ingredients, lutein and zeaxanthin, are "misleading" and "erroneous", leading eye-health researchers tell NutraIngredients.
'Well-established science does not support need for 3 carotenoid combinations for eye health formulations': Kemin experts
18-Jan-2013 - A recent study that proposed the necessity of including meso-zeaxathin in eye health formulas along with lutein and zeaxanthin has been challenged by scientists at Kemin.
Eye health formulations may require three-carotenoid combinations, says ‘important and novel’ data
15-Jan-2013 - A combination of three carotenoids - lutein, zeaxanthin and meso-zeaxanthin – may be needed to boost retinal levels and support eye health, suggests new data from Ireland and the UK.
2000-year-old food supplements found in Tuscan shipwreck
08-Jan-2013 - Italian researchers have uncovered zinc food supplements thought to treat eye problems from a shipwreck off the coast of Tuscany.
Birthday gifts: Vitamins celebrate centenary with EU health claim wins
28-Nov-2012 - 2012 is turning out to be a very good year for the vitamins sector. Aside from the feel good factor of the essential nutrients turning 100, vitamins have also won a bag of health claims in the European Union to go with those already existing in other parts of the globe.
Bioriginal to distribute Norwegian krill
08-Nov-2012 - Canadian lipid specialist Bioriginal has inked a deal with Olympic Seafood to distribute the Norwegian firm’s krill offerings.
ABC bilberry article seeks to close door on adulteration
05-Nov-2012 - An article published by the American Botanical Council for the first time gathers in one place all of the information available on how bilberry extracts are being adulterated in the marketplace, said coauthor and ABC executive director Mark Blumenthal.